Boston Scientific (BSX) Long-Term Debt Repayments (2009 - 2019)

Boston Scientific (BSX) has 10 years of Long-Term Debt Repayments data on file, last reported at $2.1 billion in Q4 2019.

• For the quarter ending Q4 2019, Long-Term Debt Repayments changed N/A year-over-year to $2.1 billion; the trailing twelve-month figure through Dec 2019 stood at $3.6 billion (up 491.36% YoY), and the FY2019 full-year result was $3.6 billion, up 491.36% from the prior year.
• Long-Term Debt Repayments improved to $2.1 billion in Q4 2019, from $1.5 billion in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $2.1 billion in Q4 2019 to a low of $150.0 million in Q4 2015.
• A 5-year average of $695.2 million and a median of $375.0 million in 2017 frame the typical range for Long-Term Debt Repayments.
• Across the five-year window, Long-Term Debt Repayments jumped 40.0% in 2017 and soared 144.52% in 2019, its largest moves.
• Tracing BSX's Long-Term Debt Repayments over 5 years: stood at $150.0 million in 2015, then soared by 66.67% to $250.0 million in 2016, then soared by 60.0% to $400.0 million in 2017, then surged by 50.5% to $602.0 million in 2018, then jumped by 246.84% to $2.1 billion in 2019.
• Business Quant data shows BSX's Long-Term Debt Repayments at $2.1 billion in Q4 2019, $1.5 billion in Q1 2019, and $602.0 million in Q1 2018.